Skin manifestations corroborated by SARS-Cov-2 infection: an integrative literature review
DOI:
https://doi.org/10.33448/rsd-v10i12.20625Keywords:
Covid-19; SARS-CoV-2; Exanthema: Skin manifestation; Skin rash.Abstract
Introduction: A growing body of literature on the cutaneous manifestations of patients with Covid-19 has been reported recently, suggesting that cutaneous lesions could be potential clinical features of the disease, particularly red spots on the hands, blisters on the trunk, and itchy urticaria. In some patients affected by the disease, red itchy patches of skin associated with skin inflammation were also observed. Objective: to investigate the most prevalent distribution, types and skin manifestations among patients with Covid-19 based on case reports, case series and prevalence studies worldwide. Methodology: This is a descriptive research of the integrative literature review type. The search was carried out through online access in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO databases Information Services, September 2021. Results and Discussion: As rare as they may be, skin lesions are noticed a few days before major symptoms such as cough, fever, and shortness of breath. Generally, the lesions resemble other skin diseases. Redness, intense itching, blisters, welts, lumps and spots can reach different parts of the body such as the skin, nails and even mucous membranes. Conclusion: Despite the observation of cutaneous manifestations in patients with Covid-19, researchers are still seeking answers to the question of whether these cutaneous presentations are directly related to the virus itself or are complications of the infection.
References
Akca, U. K., Kesici, S., Ozsurekci, Y., Aykan, H. H., Batu, E. D., Atalay, E., Demir, S., Sag, E., Vuralli, D., Bayrakci, B., Bilginer, Y. & Ozen, S. (2020). Kawasaki like disease in children with COVID-19. Rheumatology, 40 (1), 2105-2115.
Alizargar, J. (2020). The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. Journal of the Formosan Medical Association, 1-2. https://doi.org/10.1016/j.jfma.2020.05.030
Askin, O., et al. (2020). Manifestações cutâneas em pacientes hospitalizados com diagnóstico de Covid-19. Terapia Dermatológica, 33 (6), 1-14.
Avellan, M. R., et al. (2020). Manifestação cutânea de COVID-19 em imagens: relato de caso. J Eur Acad Dermatol Venereol., 34 (7), 307–309.
Bailey, L. C., Razzaghi, H., Burrows, E. K., Bruno, C. & Forrest, C. B. (2020). Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatrics, 175 (2). 176-185.
Bouaziz, J., et al. (2020). Sintomas vasculares cutâneos em COVID-19: um estudo observacional francês. J Eur Acad Dermatol Venereol., 34 (8), 451–452.
Colonna, C., et al. (2020). Chilblains-like lesões em crianças após suspeita de infecção por Covid-19. Pediatr Dermatol., 37 (3), 437–440.
Ehsani, A. H., et al. (2020). Pitiríase rósea como uma manifestação cutânea de COVID-19 infecção . J Eur Acad Dermatol Venereol., 34 (8), 436–437.
Figueiredo, B. Q., et al. (2021). Manifestação da Doença de Kawasaki sob espectro clínico da Covid-19: uma revisão sistemática de literatura. Research, Society and Development, 10 (11), 1-11. https://doi.org/10.33448/rsd-v10i11.19852
Galván, C. C., et al. (2020). Classificação das manifestações cutâneas de COVID-19: um estudo prospectivo de consenso nacional rápido na Espanha com 375 casos. Br J Dermatol., 4 (183), 71–77.
Joob, B., et al. (2020). COVID-19 pode apresentar erupção cutânea e ser confundido com dengue. J Am Acad Dermatol., 82 (177), 1-10.
Kaur, I., et al. (2020). Doença por coronavírus (COVID-19): uma revisão atualizada com base no conhecimento atual e na literatura existente para dermatologistas. Dermatol Ther., 33 (13677), 60-65.
Landa, N. (2020). Chilblain-like lesões em pés e mãos durante a pandemia COVID-19. Int J Dermatol., 59 (7), 739–743.
Marzano, A. V., et al. (2020). Exantema semelhante à varicela como uma manifestação cutânea específica associada à Covid-19: série de casos multicêntricos de 22 pacientes. International Journal of Dermatology, 50 (3), 439-444.
Perna, A., et al. (2021). Manifestações cutâneas em pacientes com Covid-19: uma revisão sistemática. International Journal of Dermatology, 60 (5), 547-553.
Recalcati, S., et al. (2020). Lesões cutâneas acrais na época de COVID-19. J Eur Acad Dermatol Venereol., 16 (3), 1-2.
Sachdeva, M., et al. (2020). Manifestações cutâneas de Covid-19: relato de três casos e revisão de literatura. International Jouurnal of Dermatology, 98 (2), 75-81.
Sameni, F., et al. (2020). Covid-19 e manifestações cutâneas: uma visão geral de relatos de caso e mta-análise de estudos de prevalência. Frontiers in Medicina, 7 (57), 1-14.
Suchonwanit, P., et al. (2020). Manifestações cutâneas em COVID-19: lições aprendidas de evidências atuais. J Am Acad Dermatol., 83 (1), 57-60.
Tammaro, A., et al. (2020). Manifestações cutâneas em COVID-19: as experiências de Barcelona e Roma. J Eur Acad Dermatol Venereol., 34 (7), 306-307.
Tang, K., et al. (2020). Manifestações cutâneas da Doença do Coronavírus 2019 (COVID-19): uma breve revisão . Dermatol Ther., 3 (7), 40-50.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Iuri Pimenta Oliveira; Bárbara Queiroz de Figueiredo; Rúbia Carla Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
